Aclidinium bromide: new LAMA for symptom relief in COPD

Aclidinium bromide (Eklira Genuair), a new inhaled LAMA, is licensed as maintenance treatment to relieve symptoms in COPD. In our New products review, Steve Chaplin presents the clinical data relating to it efficacy and adverse events, and Dr Richard Russell discusses its place in treatment.

Aclidinium bromide new LAMA for symptom relief in COPD

Add yours ↓
Web design and marketing agency Leamington Spa